药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dicyclomine
Bedaquiline
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Bedaquiline.
Dicyclomine
Antazoline
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Antazoline.
Dicyclomine
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Nemonoxacin.
Dicyclomine
Telavancin
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Telavancin.
Dicyclomine
Tucidinostat
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Tucidinostat.
Dicyclomine
Garenoxacin
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Garenoxacin.
Dicyclomine
Pracinostat
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Pracinostat.
Dicyclomine
Terlipressin
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Terlipressin.
Dicyclomine
Probucol
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Probucol.
Dicyclomine
Gemifloxacin
The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Propafenone.
Dicyclomine
Papaverine
The risk or severity of QTc prolongation can be increased when Papaverine is combined with Propafenone.
Dicyclomine
Dimenhydrinate
The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Propafenone.
Dicyclomine
Granisetron
The risk or severity of QTc prolongation can be increased when Granisetron is combined with Propafenone.
Dicyclomine
Artemether
The risk or severity of QTc prolongation can be increased when Artemether is combined with Propafenone.
Dicyclomine
Macimorelin
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Macimorelin.
Dicyclomine
Glasdegib
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Glasdegib.
Dicyclomine
Ribociclib
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Ribociclib.
Dicyclomine
Asenapine
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Asenapine.
Dicyclomine
Vandetanib
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Vandetanib.
Dicyclomine
Temafloxacin
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Temafloxacin.